QUEST DIAGNOSTICS INCORPORATED for QUEST DIAGNOSTICS INCORPORATED
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 1st Quarter - Report (this page) | Apr 21, 2025 | $410,000 | Replaced |
| 1st Quarter - Amendment | Jan 20, 2026 | $330,000 | Yes |
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Federal policy and programs regarding oncology research and development related to cancer screening, diagnosis, and survivorship Federal policy related to strengthening the clinical laboratory workforce Food and Drug Administration (FDA) policies related to diagnostics and laboratory regulation
| Lobbyist | Covered position, as disclosed |
|---|---|
| EMMA LANGE | — |
| SHERRY HARPER WIDICUS | — |
Medicare/Medicaid MMM
P.L. 118-22/H.R. 6363 - Further Continuing Appropriations and Other Extensions Act, 2024, provisions related to Medicare reimbursement for clinical diagnostics and pathology laboratory services Federal policy related to coverage and reimbursement of clinical laboratory services under the Medicare program
| Lobbyist | Covered position, as disclosed |
|---|---|
| EMMA LANGE | — |
| SHERRY HARPER WIDICUS | — |
Budget/Appropriations BUD
FY 2026 appropriations related to clinical laboratory workforce, PFAS and cardiovascular disease testing
| Lobbyist | Covered position, as disclosed |
|---|---|
| EMMA LANGE | — |
| SHERRY HARPER WIDICUS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.